Identification of Biological and Pharmaceutical Mast Cell- and Basophil-Related Targets

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378050%3A_____%2F16%3A00483285" target="_blank" >RIV/68378050:_____/16:00483285 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1111/sji.12436" target="_blank" >http://dx.doi.org/10.1111/sji.12436</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/sji.12436" target="_blank" >10.1111/sji.12436</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Identification of Biological and Pharmaceutical Mast Cell- and Basophil-Related Targets

Popis výsledku v původním jazyce

In this letter to editor, 20 students and eight trainers from 11 countries all across Europe met at the two-day training school action held in Uppsala, Sweden. In the frame of the COST Action BM1007 “Mast cells and basophils - Target for Innovative Therapies they discussed various aspects of mast cells physiology. The topics summarized in the letter involved (1) mast cell and basophil development in vivo and in vitro (2) mast cell- and basophil-deficient mouse, (3) the difference between human and mouse mast cells and basophil, and (4) are tyrosine kinase inhibitors potential targets for mast cell- and basophil-driven diseases? The combined data show accumulated knowledge about mast cell and basophils physiology and suggest new possibilities to treat mast cell- and basophil-mediated diseases.

Název v anglickém jazyce

Identification of Biological and Pharmaceutical Mast Cell- and Basophil-Related Targets

Popis výsledku anglicky

In this letter to editor, 20 students and eight trainers from 11 countries all across Europe met at the two-day training school action held in Uppsala, Sweden. In the frame of the COST Action BM1007 “Mast cells and basophils - Target for Innovative Therapies they discussed various aspects of mast cells physiology. The topics summarized in the letter involved (1) mast cell and basophil development in vivo and in vitro (2) mast cell- and basophil-deficient mouse, (3) the difference between human and mouse mast cells and basophil, and (4) are tyrosine kinase inhibitors potential targets for mast cell- and basophil-driven diseases? The combined data show accumulated knowledge about mast cell and basophils physiology and suggest new possibilities to treat mast cell- and basophil-mediated diseases.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30102 - Immunology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2016

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Scandinavian Journal of Immunology

ISSN

0300-9475

e-ISSN

—

Svazek periodika

83

Číslo periodika v rámci svazku

6

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

8

Strana od-do

465-472

Kód UT WoS článku

000379922400009

EID výsledku v databázi Scopus

—